Stress and functional neurological disorders: mechanistic insights.

conversion disorder functional neurological disorder neuropsychiatry stress trauma, psychol seque

Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
07 2019
Historique:
received: 24 07 2018
revised: 11 10 2018
accepted: 11 10 2018
pubmed: 10 11 2018
medline: 18 3 2020
entrez: 10 11 2018
Statut: ppublish

Résumé

At the interface between mind and body, psychiatry and neurology, functional neurological disorder (FND) remains poorly understood. Formerly dominant stress-related aetiological models have been increasingly challenged, in part due to cases without any history of past or recent trauma. In this perspective article, we review current evidence for such models, and how research into the role of traumatic stress in other disorders and the neurobiology of the stress response can inform our mechanistic understanding of FND. First, we discuss the association between stress and the onset or exacerbation of a variety of physical and mental health problems. Second, we review the role of hypothalamic-pituitary-adrenal axis dysfunction in the neurobiology of ill-health, alongside evidence for similar mechanisms in FND. Third, we advocate a stress-diathesis model, in which biological susceptibility interacts with early life adversity, where FND can be precipitated by traumatic events later in life and maintained by psychological responses. We hypothesise that greater biological susceptibility to FND is associated with less severe remote and recent stress, and that FND precipitated by more severe stress is associated with lower biological vulnerability. This would explain clinical experience of variable exposure to historical and recent traumatic stress among people with FND and requires empirical investigation. A testable, evidence-based stress-diathesis model can inform nuanced understanding of how biological and psychological factors interact at the individual level, with potential to inform personalised treatment pathways. Much-needed research to establish the aetiology of FND will enhance clinical care and communication, facilitate effective treatment and inform prevention strategies.

Identifiants

pubmed: 30409887
pii: jnnp-2018-318297
doi: 10.1136/jnnp-2018-318297
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

813-821

Subventions

Organisme : Department of Health
ID : CS-2014-14-016
Pays : United Kingdom
Organisme : Medical Research Council
ID : G108/603
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N029488/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Roxanne C Keynejad (RC)

Section of Women's Mental Health, Health Service and Population Research Department, Institute of Psychiatry Psychology & Neuroscience, King's College London, London, UK roxanne.keynejad@kcl.ac.uk.

Thomas Frodl (T)

Department and Hospital of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Magdeburg, Germany.

Richard Kanaan (R)

Section of Cognitive Neuropsychiatry, Institute of Psychiatry Psychology & Neuroscience, King's College London, UK, London.
Department of Psychiatry, University of Melbourne, Austin Health, Austin, Heidelberg, Australia.
Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia.

Carmine Pariante (C)

Stress Psychiatry and Immunology Lab, Institute of Psychiatry Psychology & Neuroscience, King's College London, London, UK.

Markus Reuber (M)

Academic Neurology Unit, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK.

Timothy R Nicholson (TR)

Section of Cognitive Neuropsychiatry, Institute of Psychiatry Psychology & Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH